$80M investment plan will add commercial scale sterile injectables capabilities Expansion will significantly increase production capacity and operational efficiency Lexington facility…
An automated platform designed to fight against Sepsis and Antimicrobial Resistance (AMR) Enables rapid, automated microbial identification on the Bruker…
BENTONVILLE, Ark., Sept. 30, 2024 /PRNewswire/ -- HeartX, powered by HealthTech Arkansas and MedAxiom — along with numerous leading cardiology practices…
—First Multi-Center Randomized Controlled Clinical Trial in the US to Show MeMed BV's Impact on Reducing Unnecessary Antibiotics, Supporting Clinical…
Emmes Group named a 'Major Contender' in the Life Sciences Electronic Data Capture (EDC) Products PEAK Matrix® Assessment 2024 from…
Target enrollment in the chronic cohort close to completionVancouver, British Columbia--(Newsfile Corp. - September 30, 2024) - NervGen Pharma Corp.…
CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the…
SHELTON, CT / ACCESSWIRE / September 30, 2024 / NanoViricides, Inc. (NYSE American:NNVC ) (the "Company"), reports that it has…
CEO Corner segments to include additional discussion related to press releases, events, corporate updates and pipeline progress Provides interested parties…
Academic group to receive a total of $22 million for the trialLA JOLLA, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) --…